Image

Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction

Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction

Recruiting
5-20 years
All
Phase N/A

Powered by AI

Overview

This study aims to improve surgical outcomes for children and young adults with ear differences severe secondary to congenital conditions (like microtia, a condition where the ear is underdeveloped), trauma (such as dog bites), or surgical resections secondary to skin cancer. The investigators have developed a novel medical device to shape cartilage into pre-determined shapes that, once assembled, assists the surgeon in creating an anatomically accurate cartilaginous ear framework, reduce surgery time, and minimize wire need. Other factors that might affect the quality of surgical outcomes will be examined in clinical trial participants.

Description

Cartilage-based ear reconstruction allows to address congenital anomalies, such as microtia, as well as deformities due to trauma or oncologic resection by replacing like with like tissue. Autologous reconstruction involves harvesting and carving rib cartilage into subunits, which are then assembled with numerous steel wires. Current challenges of the technique include operator-dependent and inconsistent outcomes, prolonged anesthesia, need for wire or suture fixation, wire extrusion, cartilage resorption, and overall high cost. The previously published prototype device utilized specialized blades to standardize this process.

Given the complexity of auricular reconstruction and the suboptimal outcomes by most plastic surgeons globally, there is a pressing need for a standardized, enhanced, and accessible method for ear framework carving.

If successful, this project has the potential to improve plastic surgeons' technical proficiency in producing anatomically accurate auricular frameworks. Achieving these aims could substantially advance reconstructive clinical techniques in clinical practice and broaden access to satisfactory ear reconstruction beyond the limited number of highly specialized centers. Furthermore, the novel blade design has the potential to reduce the need for wire suturing, while also reducing overall framework production time, anesthesia duration, and costs.

Additionally, as the interest in the use of cadaveric cartilage in clinical practice increases (to avoid donor-site morbidity, expand reconstructive options for elderly patients with traumatic or oncologic defects, and reduce both anesthesia time and cost), this study will provide valuable preliminary insight into the resorption rate of cartilaginous constructs and potential differences in resorption rate between autologous and cadaveric frameworks.

Comparing hand-carved and blade-cut techniques for both autologous and cadaveric cartilage, the study will enhance understanding of potential differences in resorption rate between these methods and cartilage sources.

This study aims to: 1. Promote framework production through precise blade-cutting, facilitating the construction of cartilaginous ear frameworks while improving outcomes and reducing operative time and costs; 2. Standardize framework production independently of operator skill. 3. Reduce the number of wires required for construct fixation, further contributing to decreased operative time and cost; 4. Minimize the risk of wire extrusion by limiting wires usage during framework production through the novel blade design. 5. Compare differences in framework appearance, stability, time to production, operative time, intraoperative morbidity, and construct resorption within the first year postoperatively when using cadaveric cartilage instead of autologous tissue.

Eligibility

Inclusion Criteria:

  • Patients aged 5-20 years seeking to undergo surgical ear reconstruction or microtia repair under general anesthesia through NCH-FL
  • Pre-existing physical deformity of the ear necessitating surgical reconstruction
  • Patient of sufficient health to undergo surgery under general anesthesia
  • Availability of autologous rib cartilage or consent for use of cadaveric cartilage
  • Parental or legal acceptable representative (LAR) permission obtained for inclusion in the study; patient assent obtained where age-appropriate
  • Sufficient fluency in English or Spanish to complete patient/parent surveys

Exclusion Criteria:

  • Patients who will be ≤4 years old, or ≥21 years old at time of surgery
  • Patients with ear deformities do not require surgical correction
  • Patient's whose ear reconstruction surgery will be performed somewhere other than Nemours Children's Hospital - Florida
  • Patients without sufficient rib cartilage for processing via the Nagata technique for auricular reconstruction and who do not desire cadaveric cartilage use
  • Patients determined to be in poor health to undergo surgery under general anesthesia
  • Parental or LAR permission cannot be obtained, and/or patient of sufficient age and cognitive capacity declines to assent
  • Lack of fluency in English or Spanish to complete patient/parent surveys

Study details
    Microtia
    Congenital
    Microtia
    Microtia-Anotia
    Ear Deformities
    Acquired
    Ear Deformity External
    Ear Malformation
    Ear Cartilage

NCT07154667

Nemours Children's Clinic

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.